BDBM502344 2-methoxy-N- {4-[1-methyl- 7-(1-methyl- 1H-benzo- imidazole-2- yl)-[1,2,4]tri- azolo[4,3- a]quinoxaline- 4-ylamino]- butyl}- benzamide::US11028090, Example 237

SMILES COc1ccccc1C(=O)NCCCCNc1nc2cc(ccc2n2c(C)nnc12)-c1nc2ccccc2n1C

InChI Key InChIKey=UDGDTQZZXJICRK-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 502344   

TargetBromodomain-containing protein 4(Homo sapiens (Human))
Dong Wha Pharm.

US Patent
LigandPNGBDBM502344(2-methoxy-N- {4-[1-methyl- 7-(1-methyl- 1H-benzo- ...)
Affinity DataIC50:  0.600nMAssay Description:The following experiment was performed to evaluate the ability of [1,2,4]triazolo[4,3-a]quinoxaline derivative of the present invention to inhibit th...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent